Keyword: cancer drugs


Ono to Acquire Deciphera for $2.4 Billion

02.05.2024 -

Japan’s Ono Pharmaceutical agreed to acquire US cancer-therapy company Deciphera Pharmaceuticals for approximately $2.4 billion. Deciphera focuses on innovative cancer...


EU Commission Approves Pfizer’s Takeover of Seagen

20.10.2023 -

The US pharmaceutical company Pfizer has been cleared to acquire Seagen, a biotech company focused on developing cancer treatments.


EU Investigates Aspen for Price Gouging

18.05.2017 - The European Commission (EC) is investigating South African pharmaceutical producer Aspen Pharmacare on charges it raised the price of five cancer drugs by “several hundred per...


AstraZeneca Cancer Drug Breakthrough

10.02.2016 - The combination of two cancer drugs from UK-Swedish drugs maker AstraZeneca and its biologics research and development arm MedImmune could be a potential breakthrough in treating a...


New Immunotherapy Coalition Launched in US

13.01.2016 - Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...


AstraZeneca Confirms Talks with Acerta

15.12.2015 - AstraZeneca has confirmed speculation that it is “exploring potential strategic options” with Acerta Pharma, a privately owned biotech firm with operations in the Netherlands and...


Merck Serono in Spanish Drug Development Pact

23.12.2013 - Merck Serono, the biopharmaceuticals division of Germany's Merck KGaA, has signed a global license agreement with the Spanish National Research Center (CNIO) in Madrid on cancer...


Roche to Spend $880 Million on Manufacturing, Create 500 Jobs

14.10.2013 - Swiss drug maker Roche is to invest 800 million Swiss francs ($880 million) in its global manufacturing facilities over the next five years, creating 500 jobs, as it prepares for...